Concepedia

Lambros Vamvakas

LV

27

Publications

835

Citations

18

H-Index

1998

Active since

Affiliations

University Hospital of Heraklion(Current)

Hellenic Oncology Research Group

National and Kapodistrian University of Athens

University of Crete

Metaxa Hospital

Lambros Vamvakas is an author at University Hospital of Heraklion specializing in oncology, medicine, and cancer therapeutics.

Top concepts

Publications per year

1998–2021

27

Publications

27

Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study

Athanasios Karampeazis, Alexandra Voutsina, John Souglakos et al. · Cancer · 2013 · 111 citations · Full text

Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

Christos Emmanouilides, G. Sfakiotaki, Nikolaos Androulakis et al. · BMC Cancer · 2007 · 102 citations · Full text

A Multicenter Phase II Study of Docetaxel in Combination with Gefitinib in Gemcitabine-Pretreated Patients with Advanced/Metastatic Pancreatic Cancer

Michail Ignatiadis, Aris Polyzos, George P. Stathopoulos et al. · Oncology · 2006 · 47 citations

Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial

Vassilis Georgoulias, Nikolaos Androulakis, Αthanasios Kotsakis et al. · Lung Cancer · 2007 · 46 citations

, , +10

Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study

Konstantinos Rounis, Dimitrios Makrakis, Alexandros-Pantelis Tsigkas et al. · Translational Lung Cancer Research · 2021 · 43 citations · Full text

Rows per page

1–5 of 27